Management of disseminated superficial actinic porokeratosis and
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453902/
WEBMay 6, 2021 · DSAP lesions are premalignant with conversion rates of 7.5 to 10%, most commonly to SCC; thus, there is a need to ensure that DSAP is treated effectively early in the disease course. 3, 4 DSAP can be difficult to manage; however, treatment may include topical imiquimod and fluorouracil, vitamin D 3 analogues, topical and oral retinoids, …
DA: 93 PA: 54 MOZ Rank: 13